FDA Announces ‘Green List’ of Foreign GLP-1 Ingredient Manufacturers
A U.S. Food and Drug Administration (FDA) sign is seen outside the agency’s White Oak campus in Silver Spring, Md., on July 17, 2025. Issam Ahmed/AFP via Getty Images The Food and Drug Administration recently announced new measures to prevent the import of dangerous foreign counterfeits of GLP-1 drug ingredients, which are being used to